Evidence map›Paper›PMID 18641330›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Modulation of T cell activation by stomatin-like protein 2.

Mark G Kirchhof, Luan A Chau, Caitlin D Lemke, Santosh Vardhana, Peter J Darlington, Maria E Márquez, Roy Taylor, Kamilia Rizkalla, Isaac Blanca, Michael L Dustin and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The plasma membrane as a capacitor for energy and metabolism.American journal of physiology. Cell physiology · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Mark G KirchhofFOCIS Centre for Clinical Immunology and Immunotherapeutics, Robarts Research Institute, and Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
Luan A Chau
Caitlin D Lemke
Santosh Vardhana
Peter J Darlington
Maria E Márquez
Roy Taylor
Kamilia Rizkalla
Isaac Blanca
Michael L Dustin
Joaquín Madrenas
Western University · CACentral University of Venezuela · VELondon Health Sciences Centre · CAOrganogenesis (United States) · US

Funding

MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
Requirement for Sensitive T Cell Response to AntigenR37AI043542 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL LORAN · 2007 to 2016
$3.6M
NIAID NIH HHS R01-AI43549NIAID NIH HHS R37 AI043542NIGMS NIH HHS T32 GM007308NIGMS NIH HHS T32-GM07308
6 · The paper itself

Abstract

T cell activation through the Ag receptor (TCR) requires sustained signaling from signalosomes within lipid raft microdomains in the plasma membrane. In a proteomic analysis of lipid rafts from human T cells, we identified stomatin-like protein (SLP)-2 as a candidate molecule involved in T cell activation through the Ag receptor. In this study, we show that SLP-2 expression in human primary lymphocytes is up-regulated following in vivo and ex vivo activation. In activated T cells, SLP-2 interacts with components of TCR signalosomes and with polymerized actin. More importantly, up-regulation of SLP-2 expression in human T cell lines and primary peripheral blood T cells increases effector responses, whereas down-regulation of SLP-2 expression correlates with loss of sustained TCR signaling and decreased T cell activation. Our data suggest that SLP-2 is an important player in T cell activation by ensuring sustained TCR signaling, which is required for full effector T cell differentiation, and point to SLP-2 as a potential target for immunomodulation.

Indexed as

ActinsBlood ProteinsB-LymphocytesCells, CulturedHumansInterleukin-2Lymphocyte ActivationLymphoid TissueMembrane ProteinsProtein BindingProtein TransportReceptors, Antigen, T-CellRNA, Small InterferingT-LymphocytesUp-RegulationActinsBlood ProteinsInterleukin-2Membrane ProteinsReceptors, Antigen, T-CellRNA, Small InterferingSTOML2 protein, human

Identifiers

PMID18641330
PMCPMC2913160
OpenAlexW1583700542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.